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The metabolite proﬁles of Sutherlandia frutescens populations may vary depending on their geographical location, affecting the quality of plant-based
pharmaceutical products generated from this species. This paper aims at using metabolic proﬁling through liquid chromatography mass spectrometry (LC–
MS) to assess the metabolite content of seed pods from populations of the medicinal plant S. frutescens growing in geographically different environments.
Terpenoid (retention time: 7.5–9.0 min) and ﬂavonoid (retention time: 15.0–19.0 min) regions of the chromatograms were useful in distinguishing
between samples and ﬁve distinct clusters were revealed after principal component analysis (PCA). This may assist in tracing the region where plants
actually come from and the identiﬁcation at the subspecies level. To increase the class separation and simplify interpretation, we focused on those
populations from the arid Karoo and the coastal Gansbaai area, applying orthogonal partial least squares discriminant analysis (OPLS-DA) to organize these
into two clear groups. The presence or absence of sutherlandioside B (SU1) and its derivatives contributed signiﬁcantly to the separation of the Karoo plants
from those from the Gansbaai cluster. Processing procedures of herbal products require standardization, but this becomes challenging when plants do not
contain key chemical principles. Extracts from the Gansbaai population had virtually undetectable levels of SU1; consequently products manufactured from
farmed plants originating from this region may lack these compounds, which are now proposed to be anti-cancerous. There were several sutherlandioside-
type metabolites that distinguished populations from each other. These chemicals may add new knowledge in terms of the broader metabolomic
understanding of Sutherlandia populations and their potential pharmacological action. In vitro plants generated as part of a commercialization–conservation
strategy had a similarmetabolite proﬁle to non-propagated plants. In fact, these plants could be traced to theWest Coast populations, further conﬁrming their
identity. This study highlighted that SU1 cannot be used as the only quality control marker for Sutherlandia products, since it does not occur in all
populations and there is no conclusive evidence that it is the main active ingredient of the plant. The effect of α-naphthalene acetic acid (NAA) at 1 mg l−1
was tested on in vitro plants. Sutherlandiosides and sutherlandins were detectable in treated plants. Although the treatment had impacts on the growth
capacity of plants, SU1 did not accumulate at higher levels in auxin-treated plantlets. The similarity of micropropagated plants to wild plants proved that
tissue culture does not have deleterious effects on the chemistry of Sutherlandia plants. Metabolomic approaches using LC–MS are thus an important
feature as a diagnostic tool and should be integrated into the herbal product manufacturing process utilizing Sutherlandia and its extracts.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.
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The leguminous plant Sutherlandia frutescens (syn. Lessertia
frutescens, Fabaceae) is the only indigenous, South African
medicinal plant that is known as the “cancer bush” (Van Wyk
et al., 2009). It displays bright red to orange flowers (Fig. 1A–B),
one of the distinguishing features of this plant. Even thoughreserved.
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1895 when Smith reported that these plants can ‘cure malignant
tumours, delaying the progress of true cancer’ (Smith, 1895), the
debate on this aspect is still ongoing. Although reports based on
its cancer preventing and therapeutic capacity are often conflicting,
S. frutescens has become a highly-valued commercialized plant for
the production of a variety of phytopharmaceutical products (Van
Wyk and Albrecht, 2008). It is well known as a ‘multi-functional,
all-purpose’ herbal remedy that stands inextricably linked to the
anthropology of Nama, Khoi and San populations (Fernandes
et al., 2004). It is taken as a supportive treatment for a wide
array of ailments, suggesting a plethora of metabolites withA C
B
D
Fig. 1. A) Characteristic red flowers of Sutherlandia frutescens of a plant from theWest
pod of a ‘garden-grown’ S. frutescens plant (origin unknown) with seed inside; D) Seed p
in a sandy soil habitat.pharmacological activity (Van Wyk and Albrecht, 2008).
Sutherlandia is thus consumed for stomach problems, diabetes,
anxiety and stress, inflammation, and microbe-related diseases,
amongst a range of others (Moshe et al., 1998; Fernandes et al.,
2004). It is also sold to assist with the control of sugar
homeostasis in diabetics due to its proven hypoglycemic action
(Chadwick et al., 2007). The latest research on Sutherlandia
extracts using animal models shows how it regulates insulin and
fatty acid metabolism for purposes of controlling Type 2 diabetes
(MacKenzie et al., 2009, 2012). It has a growing reputation as an
adoptogen (Van Wyk, 2012) and has been highlighted as an
appetite-stimulant, helping to reduce muscle atrophy. It isCoast area ofMelkbostrand; B) Plants in flower growing in a coastal area; C) Seed
od of a wild plant that is undergoing colourimetric changes during its development
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through its immune-boosting effects (Fernandes et al., 2004; Van
Wyk and Albrecht, 2008).
The response to the chemical identification and quantification
of secondary metabolites and broader metabolomic information
on this herb (Tai et al., 2004; Olivier et al., 2009; Avula et al.,
2010) has been slow, despite it featuring prominently in the
commercial range of phytopharmaceutical products in South
Africa. Consequently, information on the chemical composition,
both quantitative and qualitative aspects, remains fragmented and
disparate. The amino acid chemistry has received better attention
than the secondary metabolites and so several amino acids have
been used in the past for quality control purposes (consult
Mncwangi and Viljoen, this issue). A growing body of evidence
confirming its anti-proliferating and apoptotic effects using
cancer cell lines and leaf extracts is now available. For examples
refer to the work of Tai et al. (2004; human leukemia and breast
cancer); Chinkwo (2005; cervical cancer); Stander et al. (2007;
2009); Vorster et al. (2012; breast cancer); and Skerman et al.
(2011; oesaphageal cancer). Whereas most of these studies
showed some anti-cancer activity at the concentrations tested,
it is highly debatable whether these concentrations have
physiological efficacy or not. Most dietary supplements, in the
form of capsules or tablets, contain SU1 at 1–5 mg g−1 average
weight of sample (Avula et al., 2010). Sutherlandia plants are
found in varying biomes in different geoclimactic locations and
are thus tolerant to different environments. This invariably leads
to a tremendous amount of chemical heterogeneity, particularly
between different populations. Recent focus on understanding
key metabolites that may feature in the broad bioactivity of these
plants has led to the appreciation of its complex chemistry being a
cocktail of flavonoids, triterpenes, saponins and other plant
steroids (Van Wyk and Albrecht, 2008 and references therein).
Natural genetic hybridization changes the chemotypic expression
in plants and this ultimately has a profound influence on the
metabolome (Kuhajek et al., 2004). Some consider S. frutescens
to be a species complex as it shows a mosaic of highly variable
morphological and chemical characteristics that are coupled
to distinct, discontinuous geographical localities (Van Wyk and
Albrecht, 2008). Furthermore, it has been postulated that
Sutherlandia undergoes continuous and extreme metabolomic
variation and that certain extremely unlikely metabolite patterns,
particularly with regards to the flavonoids and triterpenoids,
contribute significantly to pharmacological mixtures that have the
capability to induce tumour-cell death selectively (Albrecht,
2008). Chemical signatures that characterize these plants are
thus required, particularly for assessing the quality of herbal
products and to assist with standardization. The recent isolation
and structural elucidation of unique chemicals, aptly named
sutherlandiosides (terpenoids/cycloartanol glycosides) (Fu et al.,
2008, 2010) and sutherlandins (quercetin and kaempferol-
derived flavonoids) (Avula et al., 2010) has been a major
breakthrough. This provides us with an opportunity to exploit
these compounds, solely synthesized by S. frutescens, for
metabolite fingerprinting purposes as these are now thought
to be linked to the inhibitory effects of extracts on cancer cell
lines.Imminent commercialization within the international natural
products industries, which has rigorous quality standards,
requires quality-assured plant material produced using high-
level manufacturing practices. Like so many other medicinal
plants, Sutherlandia is often collected from wild populations as
few farmers are actively engaged in cultivating this plant as a crop
(Van Wyk and Albrecht, 2008). The highly variable nature of
Sutherlandia plants thus presents a quality control challenge. In
general, farming of medicinal plants in South Africa is limited.
The current level of farm production does not meet commercial
demand, even with developments of large-scale farming by
individual companies since the late 1990s (Van Wyk, 2012).
Alternative strategies to access this biodiversity that are
ecologically friendly and commercially sustainable are required.
With this in mind, we generated plants in tissue culture (Colling
et al., 2010) as part of a germplasm conservation practice to
reduce harvesting pressures. This would also provide large
volumes of quality stock for an ever-growing pharmaceutical
industry. Wild plant populations exhibit inherent genetic-to-
chemical heterogeneity with some populations being superior to
others, in vitro culture offers a method of fast preserving desired
chemo-elite types. Cultivation of Sutherlandia through seed
technology is not a feasible option. With seed germination being
precarious and unpredictable, requiring chemical treatments to
break dormancy (Shaik et al., 2008), in vitro propagation has
been explored by Colling et al. (2010) and Shaik et al. (2010,
2011). There are many advantages to tissue culture for
Sutherlandia, including: 1) it allows for the rapid production of
disease-free plants using leaf material, which is an easily
renewable explant source for culture induction; 2) propagules
may fit into a phytopharmaceuticals supply chain platform using
in vitro-derived plants to produce a cultivated field crop; 3) as
plants are produced under aseptic conditions, this reduces
quarantine restriction related to international export of biomate-
rial; and, 4) as plants are available all year round this negates
problems associated with inaccessibility in the case of plant
varieties that are adapted to unique niche environments (Nigro et
al., 2004; Fennell et al., 2006).
Plant tissue culture has been part of biotechnological
approaches that have fast-tracked our overall understanding of
plant biosynthetic pathways and their regulation. Micro-
propagation techniques have aided in cultivating new genetic
variants, leading to establishment of superior plant cultivars
that are now in agricultural cultivation. Moyo et al. (2011)
emphasized the role of mass micropropagation of medicinal
cultures synthesizing active principles using bioreactors as one
direction to ‘innovate the concept of indigenous medicinal plant
knowledge in South Africa’, creating new economic growth
opportunities. Several bioreactor protocols have been described
for Sutherlandia, which can assist with standardization (Shaik
et al., 2011).
Here, a comparative metabolomic study using high-throughput
liquid chromatography–mass spectroscopy (LC–MS) of a set
of plant samples from distinct geographic locations (Table 1) was
explored. It was hoped that this would reveal extremely rare
chemo-variants, with higher levels of sutherlandiosides and
sutherlandins, which in the future would be worth evaluating
Table 1
Geographic locations of Sutherlandia species collections sampled analysed with targetted and non-targetted LC–MS. The concentration of sutherlandiose B (SU1) is
represented in percentage (%) dry mass (DM).
No. Facile name Details of location GPS S (south) GPS E (east) SU1 (% DM)
1 Garden grown-A Spontaneous appearance in 2010 35° 51′ 32.12′ 18° 39′ 45.69′ 0.002 a
2 Garden grown-B Growth continuation in 2011 35° 51′ 32.12′ 18° 39′ 45.69′ 0.001 a
3 Karoo Winifred Grobler, Murraysburg 31° 57′ 46.31′ 23° 45′ 36.20′ 0.993 g
4 Albertina Near Albertina 34° 11′ 58.89′ 21° 35′ 00.29′ 0.642 d
5 Stanford Between Hermanus and Gansbaai 34° 26′ 29.67′ 19° 27′ 19.84′ 0.008 a
6 Grootbos Between Stanford and Gansbaai 34° 32′ 20.42′ 19° 24′ 46.97′ 0.002 a
7 Blomerus Beyond Grootbos 34° 35′ 31.59′ 19° 32′ 13.96′ 0.005 a
8 Gansbaai Four km from town towards Stanford 34° 33′ 03.61′ 19° 23′ 38.74′ 0.000 a
9 Franskraal Between Kleinbaai and Franskraal 34° 37′ 36.54′ 19° 28′ 14.30′ 0.006 a
10 Uilkraalmond Walker Bay Nature Reserve 34° 37′ 02.55′ 19° 26′ 21.09′ 0.000 a
11 Blouberg Used by VULA Pty Ltd to bind sand 33° 47′ 35.63′ 18° 27′ 38.35′ 0.170 b
12 Namaqualand Unknown 0.526 c
13 Weskus Near Mykonos 33° 02′ 29.19′ 18° 02′ 37.04′ 0.836 f
14 Yzerfontein Between N7 and Yzerfontein 33° 00′ 02.74′ 18° 14′ 24.80′ 0.198 b
15 Duwisib Duwisib Castle South Namibia 25° 15′ 27.65′ 16° 32′ 04.48′ 0.855 e
All letters that are different represent statistical significance using the Tukey's HSD test (p≤0.5).
36 C.F. Albrecht et al. / South African Journal of Botany 82 (2012) 33–45for their pharmacological potential. To this end, dried pods
(Fig. 1C–D) from 13 different geographical locations plus two
cultivated garden specimens were studied as very little, if any,
work has been done on Sutherlandia pods. Both leaves and seed
pods are used in traditional medicine (Van Wyk and Albrecht,
2008), however, only leaf extracts have previously been studied.
We were also interested in assessing the presence of triterpenoids
and flavonoids in the pods, as this may have therapeutic
implications. Additionally, populations from various geo-spatial
regions were easily distinguishable grouping into distinct
chemical lineages using unsupervised chemometric-based clus-
tering. In vitro cultured plants could thus be easily traced to
populations of coastal origin, meeting the second aim of this study
of using LC–MS as a metabolomic diagnostic tool. Using this
feature to characterize both the quality and quantitative compo-
sition of in vitro-generated plants, we could confirm that the tissue
culture method was appropriate and that the propagules remain
true to their source chemotype. The effect of auxin, a plant growth
regulator in the form of NAA, was used in vitro to increase plant
biomass. This tissue culture application was able to generate
large, quality-assured, commercializable volumes of S. frutescens
microplants. Sutherlandins and sutherlandiosides were ideal
quality marker candidates assisting with the visualization of
mass spectrometry data.
2. Materials and methods
2.1. Plant material
2.1.1. Wild collections
The S. frutescens wild specimens were collected from
different sites throughout the Western Cape and Northern Cape
Provinces (South Africa). The collection sites are listed in Table 1
and plant collections were assigned numbers 1 to 15. Samples are
denoted according to the geographic locality where they were
harvested and characteristic taxonomic features such as bright red
flowers and pods (Fig. 1) were used by Carl F Albrecht to identify
material. Plants collected (in 2009) from populations growing inthe Melkbostrand (West Coast) for in vitro propagation are
deposited as voucher specimens in the Department of Botany and
Zoology Herbarium (Stellenbosch University).
2.1.2. In vitro culture
In vitro cultures of S. frutescens were generated as described
by Colling et al. (2010). These plants are kept in a continuous
culture system by subculturing nodal explants onto full-strength
Murashige and Skoog (1962) medium (Highveld Biological,
South Africa), supplemented with 30 g l−1 sucrose, 0.1 g l−1
myo-inositol and 10 g l−1 agar–agar (Merck, Germany). The
pH of the medium was adjusted to 5.8 using 1 M NaOH or 1 M
HCl prior to the addition of the agar. Media were sterilized by
autoclaving for 20 min at 122 kPa and 120 °C. Before aseptic
transfer under laminar flow conditions, 10 ml medium was
poured into glass test tubes (7 cm×2 cm). Routine subculture
took place at the end of four weeks, by transferring 1–2 cm
nodal explants (with one axillary bud) to glass test tubes
(7 cm×2 cm). Plastic caps were used as test tube closures and
were secured with a strip of Parafilm (American National Can™,
USA). Plantlets were left to develop in vitro inside a growth room
with a photoperiod of 16 h light and 8 h of darkness daily. The
room was fitted with cool white fluorescent tubes (Osram model
L75W/20X [F96712], USA), providing a photosynthetic photon
flux density of 50 μmol m−2 s−1. The temperature was
thermostastically controlled at 23±2 °C.
To test the effect of 1 mg l−1 α-naphthalene acetic acid
(NAA) on growth and secondary metabolite profiles, 15
explants were used. One individual explant was cultured per
test tube, representing one replicate. Fifteen replicates were
used and a randomized design was applied. As a control, NAA
was omitted from the culture medium. Plants were left to grow
for 30 days. Upon harvesting, the fresh and dry mass of the
shoots was determined, the length of each shoot was measured
and the number of axillary bud outgrowths recorded. For
metabolite extraction, samples were freeze-dried for 24 h
(Virtis Benchtop K; SP Scientific, USA) and then stored at −
80 °C until metabolite analysis.
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All in vitro culture experiments were conducted at least three
times for 28 days to generate growth data. To reiterate, fifteen
samples were used in each treatment for growth experiments.
For quantification of SU1 in the shoots, five replicates were
used to measure the SU1. All data were subjected to normality
testing (Shapiro Wilk's W test), prior to analysis of variance
(ANOVA). For the data which were not normally distributed,
Kruskal–Wallis analysis was used to separate means. When the
data were normally distributed, a Tukey's Honestly Significant
Difference (HSD) test was applied. Arcsine transformation for
all percentage data were used before ANOVA. All tests were
conducted at the 95% confidence level using the Statistica
version 8 software programme (Statsoft Inc. 2007).
2.3. Sample preparation: Metabolite profiling
All plant material was ground to a fine powder and 50 mg
from each sample was extracted with 50% (v/v) acetonitrile
(Romil far UV grade; Microsep, South Africa) containing 0.1%
(v/v) formic acid (Sigma-Aldrich, South Africa). In all cases,
ultrapure water (MilliQ) was used as a diluent. For each
extraction, 2 ml of extraction solvent was added to the plant
powder and all samples were sonicated in an ultrasonic bath for
30 min. Samples were left for 16 h in the solvent at room
temperature before analysis. To remove cell debris, samples
were filtered and diluted ten-fold before LC–MS analysis.
Extractions were performed in triplicate for statistical process-
ing and all samples were randomized to eliminate changes in
the instrument conditions over time.Fig. 2. LC–MS chromatogram of the Karoo extract of Sutherlandia showing the UV
negative mode (bottom).2.4. Liquid chromatography mass spectrometry (LC–MS)
analysis
LC–MS and LC–MS/MS analysis were conducted on a
Waters Synapt G2 quadrupole time-of-flight mass spectrometer
(Milford, MA, USA) (Fig. 2). The instrument was connected to
a Waters Acquity ultra-performance liquid chromatograph
(UPLC) and Acquity photo diode array (PDA) detector.
Ionisation was achieved with an electrospray source using a
cone voltage of 15 V and capillary voltage of 2.5 kV and both
positive and negative modes were utilized. Nitrogen was used
as the desolvation gas at 650 l h−1 and the desolvation
temperature was set to 275 °C.
2.4.1. LC Method 1
A Waters UPLC BEH C18 column (2.1×50 mm, 1.7 μm
particle size) was used and 3 μl was injected for each analysis.
The gradient started with 100% using 0.1% (v/v) formic acid
(solvent A) and this was kept 100% for 0.5 min, followed by a
linear gradient to 22% acetonitrile (solvent B) over 2.5 min, 44%
solvent B over 4 min and finally to 100% solvent B over 5 min.
The column was subjected to 100% solvent B for an additional
2 min. The column was then re-equilibrated over 1 min to yield a
total run time of 15 min. A flow rate of 0.4 ml min−1 was
applied. Data generated from these runs were subjected to
principal component analysis.
2.4.2. LC Method 2
A longer column with the same packing: Waters UPLC BEH
C18 column (2.1×100 mm, 1.7 μm particle size) was used.
The injection volume (3 μl) was kept the same as described buttrace at 260 nm (top), electro-spray ionisation in the positive mode (middle) and
Table 2
LC–MS of sutherlandins and sutherlandiosides identified using positive and negative ESI scanning and key fragment analysis.
A
Exact mass ESI negative ESI positive
[M-H]−
(Base peak)
[M+H]+
(Base peak)
[M+H-sugar]+ Fragment UV max
Sutherlandin A 740.1800 739.1722 741.1877 609.1433 303.0491 263.2; 351.2
Sutherlandin B 740.1800 739.1725 741.1884 609.1457 303.0496 255.2; 350.2
Sutherlandin C 724.1851 723.1785 725.1946 593.1517 287.0547 265.2; 351.2
Sutherlandin D 724.1851 723.1782 725.1941 593.1516 287.0558 265.2; 345.2
B
Exact
mass
ESI
negative
ESI positive
[M+formate]−
(Base peak)
[M+H]+ [M+H-H2O]+ [M+H-glu]+ [M+H-glu-H2O]
+ [M+H-glu-2H2O]
+ [M+H-glu-3H2O]
+ [M+H-glu-4H2O]
+
Sutherlandioside A 652.4186 651.4086 697.4169 653.4161 635.4272
(Base peak)
491.374 473.3629 455.3516 437.3416 419.3305
Sutherlandioside B 652.4186 651.408 697.4161 653.4281 635.4281
(Base peak)
491.3741 473.3635 455.3532 437.3417 419.3275
Sutherlandioside C 650.4030 649.3942 695.3993 651.4123 633.4034 489.3588
(Base peak)
471.3475
Sutherlandioside D 634.4081 633.3932 679.4061 635.4161
(Base peak)
617.4049 473.3629 455.352 437.3412 419.3308
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39C.F. Albrecht et al. / South African Journal of Botany 82 (2012) 33–45the gradient started with 80% of solvent A which preceded a
holding step of 0.5 min. This was then followed by a linear
gradient to 44% solvent B over 14.5 min leading to 100%
solvent B (1 min). The column was kept at 100% solvent B for
another minute followed by re-equilibration over 4 min to yield
a total run time of 22 min. A flow rate of 0.35 ml min−1 was
applied. The MS data were acquired by using a low energy of
6 V for LC–MS data and the trap collision energy was ramped
from 15 to 60 V to generate fragmentation data (MSE). MSE is
a powerful technique which enables the collection of MS
fragmentation data at all times for all compounds eluting off the
column, whereas normal LC–MS/MS techniques only perform
MS/MS fragmentation on predefined ions or criteria.A
B
Fig. 3. A) Score plot of principal component analysis based on LC–MS spectra of w
to Table 1. Three replicates were represented for each sample set but for clarity of p
based on LC–MS spectra of wild and garden-grown plants of Sutherlandia. Arrow
assigned to unknown compounds.2.5. Sutherlandioside and sutherlandin analysis
A reference standard of SU1 was used for quantification of
this chemical in both seed pods of wild plants, seed pods of
cultivated plants grown in the garden and in vitro leaves. This
standard was isolated by V. Gabrielse (refer also to Van Wyk
and Albrecht, 2008). The SU1 calibration curve had a linear
range of 0 to 50 ppm (R2=0.998) with a detection limit of
10 ppb. The relative standard deviation (%RSD) between the 3
replicate injections was less than 3% for all samples. The other
sutherlandiosides (A, C, and D) together with the sutherlandins
(A, B, C and D), were identified using the techniques described
in detail by Avula et al. (2010). In conjunction with theild and garden-grown plants of Sutherlandia. Populations are labelled according
oints, only one is shown. B) Loading of principal component analysis analysis
s indicate sutherlandioside B and sutherlandioside-like terpenoids. Circles are
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Fig. 4. A) Score plot of orthogonal partial least squares discriminant analysis of LC–MS spectra of Gansbaai and Karoo plant populations of Sutherlandia. Three
replicates are represented for each sample set. B) Score plot of orthogonal partial least squares discriminant analysis of LC–MS spectra of Gansbaai and
garden-grown plant populations of Sutherlandia. Three replicates were analysed for each sample set but for simplicity only one is shown.
40 C.F. Albrecht et al. / South African Journal of Botany 82 (2012) 33–45presented chemical structures (Avula et al., 2010), the identifi-
cation was based on UV spectra (supplementary data), the
retention time (Fig. 2) and MS data (Table 2; supplementary
data).
2.6. Chemometric data processing
The Masslynx version 4.1 (Waters) was used to acquire and
process the data. Targetlynx and Markerlynx were the appli-
cation managers within Masslynx software that were used to
quantify SU1 for ex vitro wildtypes (Table 1, Figs. 3–4) and
in vitro cultured plantlets and to perform the multivariate anal-
ysis, respectively. The Markerlynx method was set to process
data from a retention time of 2.1 to 9.8 min, over the mass
range 250 to 1200 Da and a mass window of 0.01 Da.Smoothing and noise elimination level of 1000 were used. The
PCA-X model with pareto scaling was used as an unsupervised
multivariate cluster technique. Pareto scaling increases the
contributory effects of low concentration metabolites but does
not amplify noise and artefacts linked to metabolomics data
(Cloarec et al., 2005). Therefore, this simplifies the interpreta-
tion of loading score plots (Heyman and Meyer, 2012).
Inter-relationships were revealed through PCA groupings,
clusters and outliers amongst 16 observations for 67 variables
based on 3 components (MS data, relative abundances and
spatial distribution) for the test populations. Three biological
replicates and three technical replicates were injected randomly
for each test sample. The instrument variation was negligible
and replicates clustered close to each other (supplementary
data), therefore only one representative is shown to simplify the
41C.F. Albrecht et al. / South African Journal of Botany 82 (2012) 33–45data (Fig. 3). Intra-replicate patterns are shown for Fig. 4A
depicting the OPLS-DA groups. Separation is based on 16
observations and 67 variables for Fig. 4A. Pareto scaling was
also used for the OPLS-DA test.3. Results and discussion
3.1. Profiling of wild and garden-grown populations
The detection of sutherlandins and sutherlandiosides in
extracts of Sutherlandia is being developed as a quality control
protocol and here we were able to successfully identify some of
these flavonoid and terpenoid compounds using various LC–
MS modes (using positive and negative ESI, and MSE). In fact,
four sutherlandins and four sutherlandiosides were identified
through integrating the retention time, UV spectra and MS
fragmentation data for accurate mass-based identification
(Table 2). The LC spectral traces and representative structures*
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Fig. 5. Effect of 1 mg l−1 NAA on in vitro plants of Sutherlandia. A) Dry mass;
B) shoot length and C) number of axillary bud outgrowths. * Indicates statistical
significance (p≤0.05; N=18 for the untreated control and 16 for the
NAA-treated plants).are presented in Fig. 2. The LC‐ESI–MS data from positive and
negative modes is presented in Table 2 and the fragmentation
patterns for the eight biomarkers were very similar to those
published by Avula et al. (2010). For example, sutherlandin A,
showing the m/z 303.0491 fragment indicative of quercetin and
sutherlandin D, showing the m/z 287.0558 fragment indicative
of the kaempferol moiety, were detected using ESI+ (Table 2;
Supplemental data). The theoretical exact mass of SU1 is
652.4186. This corresponds to the following ions detected
using electrospray ionisation in the negative mode (ESI−): m/z
651.4080 [M-H]−; and m/z 697.4161 [M+formate]−. In
electrospray ionisation in the positive mode (ESI+): the fol-
lowing ions were identified: m/z 653.4281 [M+H]+; m/z
635.4281 [M+H-H2O]
+; m/z 491.3741 [M+H-glu]+; m/z
473.3635 [M+H-glu-H2O]
+; m/z 455.3532 [M+H-glu-2H2O]
+;
m/z 437.3417 [M+H-glu-3H2O]
+ and m/z 419.3275 [M+H-glu-
4H2O]
+. These compounds were detectable with the short LC–
MS method, although the longer method (termed LC–MS
method 2) resulted in better peak-to-peak separation. These
compounds are labelled as denoted by Avula et al. (2010) and
they are in the retention time range of 7.5–9.0 min and 15.0–
19.0 min, respectively. To assess and quantify the level of
chemotype variation between the various populations of
Sutherlandia, we subjected the spectra to multivariate analysis.
The PCA analysis of the LC–MS spectra is presented in Fig. 3A.
The PC 1 and PC 2 explain 38.87 and 17.17% of the variance and
this enabled good statistical separation amongst the different
populations according to their spatial (regional) identities.
Bearing in mind that those samples with the greatest variance
are displayed in PC 1 (Van der Kooy et al., 2008), with this data
we could develop the concept of there being at least two major
groups of S. frutescens. Those plants containing the SU10
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Fig. 6. A) Sutherlandioside B (SU1) content in propagated cultures of Sutherlandia.
The percentage value of SU1 is indicated above the bars. B) Examples of in vitro
untreated and treated (1 mg l−1 NAA) plants of Sutherlandia. N=5 for the
untreated control and 5 for the NAA-treated plants.
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the other group (Fig. 3B), with virtually no SU1, was composed
of plants that are spatially situated in the Gansbaai area. Although
speculative, the first group is most probably S. frutescens
sub-species microphylla and the second set is likely to be S.
frutescens sub-species incana, respectively. Those plants from
the south-western Overberg region (termed here as the Gansbaai
population) were associated in closer proximity on the positive
vector of PC 1, suggesting similarities in their chemical makeup.Fig. 7. LC−MS spectra for plants growing in vitro. Plants were either untreated (cent
is shown at the top.The data presented in Table 1 corroborate this notion as SU1 was
only detectable in some spatial variants. The highest level of this
chemical was recorded for the Karoo pods at 0.993% (DM) but
these were similar to the West Coast plants (Table 1), further
substantiating the PCA data. The garden grown material is
interesting as it contains some unique metabolites. These plants
were obviously not closely related to either the Karoo or
Gansbaai groups. The superior resolving power of LC–
MS-PCA analysis is artistically illustrated in this study becauseTissue culture
(control)
Tissue culture
(NAA-treated)
Sutherlandioside B
(SU1)
re) or treated with 1 mg l−1 NAA (bottom). The spectrum for Sutherlandioside B
43C.F. Albrecht et al. / South African Journal of Botany 82 (2012) 33–45it allows for even low quantity metabolites to be used for
constructing population relationships and quality assessments
(Van der Kooy et al., 2009). This may suggest similar
environmental challenges which may tightly control expression
of the SU1 phenotype (such as water deprivation), but genetic
structure cannot be dismissed. To confirm our suspicions, it may
thus be interesting to attempt to correlate metabolomic data with
geographical distribution and phylogenetic data to determine
whether metabolic characters are largely dependent on the
genome or rather the influence of the environment. Unfortu-
nately, few phylogenetic studies have focused solely on
Sutherlandia, and to date, these have often been unable to
provide resolute genetic differentiation (Van Wyk and Albrecht,
2008). An in-depth phylogenetic-metabolomic analysis is thus
long overdue for this species and its relatives.
Overall the chemistry of Sutherlandia was once more
confirmed to be complex with many constituents (close to 67
variables) being similar amongst the different populations
(Fig. 3B). Several unidentified compounds were implicated in
the separation amongst wild-collected and cultivated garden
plants. A unique compound (indicated by an arrow, Fig. 3B)
contributed to isolating the garden-grown specimens (ESI− m/z
823.3781 refer to the score loading plot). At this stage this
compound remains unidentified. The true identity of those
chemicals that are in the negative component of PC 2 (Fig. 3B)
has not been resolved in this study. However, even though
they seem to be minor constituents of the overall profile of
Sutherlandia, they may be useful markers to characterize those
plants coming from the Yzerfontein and Blouberg regions
(West Coast). The phenomenon of the Karoo-chemotype or
Gansbaai-chemotype is further emphasized through supervised
comparison by subjecting data to OPLS-DA (Fig. 4). This
method of cluster analysis validates our interpretation of there
being two major groups (variance is recorded at the 8.78%
level).
3.2. Profiling of micropropagated plants
For commercialized medicinal herbs, a more targeted
approach is generally employed which focuses on known
bioactives and so we quantified the levels of SU1 in auxin-
treated and untreated (control) in vitro plants of Sutherlandia.
Although this plant growth regulator produced more plants with
longer shoots (Fig. 5), the levels of SU1 detected in the in vitro
plants irrespective of treatment were similar (120 mg g−1 dry
mass; Fig. 6A). Consequently, NAA could be applied as a
growth regulator in tissue culture to generate a higher biomass
as it may produce a greater number of plantlets for ex vitro
planting. The number of axillary buds influences the exponen-
tial potential of the tissue culture system for bulking up stock
plants, as each node has the capacity for shoot regeneration.
In our environment, we normally do not expose the propa-
gules to plant growth regulators as the plants produced in vitro
are generally healthy and sufficient endogenous phytohor-
mones are available to maintain a high-yielding, continuous
stock culture system. Overall, treated plants had similar
chemical profiles to control plants (Fig. 7) explaining thesimilar levels in SU1 content. With the LC–MS method used
here, chromatograph traces of micropropagated plants con-
firmed the chemotype of starter material as originating in the
West Coast. The SU1 elutes at the 5.50–6.0 min of the spectra
(Fig. 7). Although several different types of metabolites have
been detected in Sutherlandia, none of these have been
irrevocably been linked to its anti-tumourigenic effects. Pres-
ently, it is postulated that terpenoids and flavonoids are the
secondary metabolites that are responsible for Sutherlandia's
anti-cancer properties. High levels of somaclonal variation
arising from inappropriate tissue culture regimes may be prob-
lematic when considering micropropagated plants for field
cultivation, as these changes may prevent acclimation and
subsequent development as field crops. As a rapid test, we used
a metabolite profiling approach to detect changes to plant
metabolism. Although not surprising, there were no apparent
abnormal chemical changes. Instead, plants resembled those from
the West Coast area of Yzerfontein, which is in close proximity
and has a similar microclimactic environment to Melkbosstrand.
This may suggest that the chemical constituents of Sutherlandia
are more closely controlled by genetic factors as opposed
to environmental influences when conditions are optimal. This
adds impetus for a phylogenetic revision which is linked to
chemotyping. There were no major qualitative differences in the
terpenoid and phenolic components of auxin-treated and
untreated (control) plants but quantitative differences for SU1
were evident when comparing these to detected levels on wild
growing populations. Lower levels of SU1were detected in the in
vitro plants (Fig. 6A). Several reasons may explain this result.
Firstly, in vitro grown plants are not subjected to the same
considerable abiotic and biotic stresses as plants from natural
populations, where secondary metabolite synthesis of defense
chemicals drives the phenotypic plasticity associated with spatial
and environmental fluctuations. Secondly, in vitro grown plants
may be considered as being young compared with plants growing
outside. Temporal control of secondary metabolism is a well-
recognized phenomenon, with older plants often exhibiting better
chemical differentiation and higher levels of key bioactive
principles. Finally, the differences observed may also be
attributable to tissue-specific SU1 accumulation and the different
plant parts used (seed pods versus in vitro leaves). It is thus
possible that the plants grown in vitro accumulate quantitatively
comparable levels of sutherlandins and sutherlandiosides when
transferred ex vitro. Accumulation of industrially important
primary metabolic biomarkers in acclimated, micropropagated
plants has been reported by several authors who detected
canavanine, gamma amino butyric acid (GABA), asparagine,
aspartic acid and pinitol (Colling et al., 2010; Shaik et al., 2010,
2011), but the detection of these putative anti-cancer terpenoids
and flavonoids in micropropagules is described and quantified
here for the first time.
4. Conclusions
Integrative LC–MS-PCA is an extremely powerful resolu-
tion technique that can be used to process and analyse data in
order to assess quality, traceability and novelty. With this
44 C.F. Albrecht et al. / South African Journal of Botany 82 (2012) 33–45method, populations of Sutherlandia were shown to differ
chemically according to their environmental lineages. Using
this approach, we identified the ‘garden-grown’ plants as being
chemically distinct and so extracts of this seemingly unique
Sutherlandia will be subjected to testing to ascertain anti-cancer
capability. Plant tissue culture did not elicit unwarranted
epigenetic mutations that could adversely affect the chemical
constitution of plants, ensuring that this propagation technique
is industrially suitable for product manufacturing.Acknowledgements
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